MP26 Guidelines for the Prescribing and Administration of Olanzapine Long Acting Injection (Zypadhera)


Category
Medicine management
Code
MP26
Issue No
Issue 1

Target Audience

All clinical staff

Purpose

The purpose document is to provide guidance on the prescribing and administration of Olanzapine Long Acting Injection (Zypadhera)

Origin

Lead executive
Medical Director

Authors details
Mental Health Pharmacist


Policy dates & history

Implementation Date

30 December 2016

Review Date

30 December 2017

Approval Meeting

Medicines Management Group

Download

MP26 Guidelines for the Prescribing and Administration of Olanzapine Issue 1.pdf

0.27MB
Download Now
Text size A- A+
Contrast options